NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Neutral

AI Analysis

Summary

NewAmsterdam Pharma announced the grant of inducement share options covering 28,000 ordinary shares to three new non-executive employees under its 2024 Inducement Plan in compliance with Nasdaq Listing Rule 5635(c)(4).

Importance:2/10

Sentiment:

0.00

inducement grantsequity compensationemployee hiringNasdaq listing rules

Related Companies

$NAMS

Read the original article

Published by GlobeNewswire Pharma on August 6, 2026 8:01 PM

Read Original